An Open-Label Fixed-Sequence Study to Assess the Effects of Itraconazole and Rifampicin on the Single-Dose Pharmacokinetics of JNJ-53718678 in Healthy Adult Subjects

Trial Profile

An Open-Label Fixed-Sequence Study to Assess the Effects of Itraconazole and Rifampicin on the Single-Dose Pharmacokinetics of JNJ-53718678 in Healthy Adult Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Aug 2016

At a glance

  • Drugs Itraconazole (Primary) ; JNJ 53718678 (Primary) ; Rifampicin (Primary)
  • Indications Respiratory syncytial virus infections
  • Focus Pharmacokinetics
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 17 Aug 2016 Status changed from recruiting to completed.
    • 20 Jun 2016 Planned End Date changed from 1 Jun 2016 to 1 Jul 2016.
    • 12 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top